Brendan Payne | Associate Director, Investor Relations |
David Main | President & Chief Executive Officer |
Barbara Troupin | Chief Medical Officer & VP, Clinical Development & Regulatory Affairs |
Kamran Alam | VP, Finance & Chief Financial Officer |
Alan Carr | Needham & Company |
Adnan Butt | Guggemheim |
Bill Tanner | Cantor Fitzgerald |
Arlinda Lee | Canaccord Genuity |
Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Aquinox Pharmaceuticals Year End 2017 Conference Call. At this time, all participants are in a listen-only mode.
Following the conclusion of the prepared remarks, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, today’s conference call is being recorded.